[Intravenous administration of amikacin sulfate for the infections complicated with hematologic disorders (author's transl)].
D000293:Adolescent; D000328:Adult; D000583:Amikacin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000150:complications; D005260:Female; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007275:Injections, Intravenous; D007612:Kanamycin / Q000031:analogs & derivatives*; D007951:Leukemia, Myeloid / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy; D018805:Sepsis / Q000150:complications / Q000188:drug therapy
D007612:Kanamycin; D000583:Amikacin